Tight Junction Proteins For Glaucoma Treatment - Trinity College Dublin - October 2018  front page preview

Tight Junction Proteins For Glaucoma Treatment - Trinity College Dublin - October 2018

Glaucoma is one of the most prevalent causes of global visual handicap. Researcher at Trinity College Dublin have developed a novel technology for reducing intra-ocular pressure by down-regulation of a number of ‘tight-j...

pdf 717.2KB

RAAVE: Get More Value and Engagement From Video Content- Trinity College Dublin - October 2018 front page preview

RAAVE: Get More Value and Engagement From Video Content- Trinity College Dublin - October 2018

RAAVE automatically transforms your existing long form video assets to make easier for users to search and consume. • Define what detail you want: e.g. summary, transcript, tag cloud, key slides/images, • RAAVE and gen...

pdf 4.3MB

Remote Radio Heads - Trinity College Dublin - October 2018 front page preview

Remote Radio Heads - Trinity College Dublin - October 2018

Demand for LTE bandwidth is increasing and frequency bands are becoming more congested. The problem is addressed by enabling spectrum sharing and increasing spectrum efficiency through better spectrum management. This sy...

pdf 1.1MB

NOD1/2 Immunomodulatory Agonists- Trinity College Dublin- October 2018 front page preview

NOD1/2 Immunomodulatory Agonists- Trinity College Dublin- October 2018

The technology offered by Trinity College relates to novel NOD modulators, particularly to NOD1 or NOD1 and NOD2 agonists, processes for their preparation, pharmaceutical compositions comprising these modulators and thei...

pdf 485.1KB

Novel Toll-like receptor agonists from Bordatella Pertussis-Trinity College Dublin- October 2018 front page preview

Novel Toll-like receptor agonists from Bordatella Pertussis-Trinity College Dublin- October 2018

Novel Toll-like receptor 2 (“TLR2”) agonists endogenously derived from Bordetella pertussis, have been discovered and have considerable potential for the development of a more effective vaccine capable of generating prot...

pdf 949.5KB